scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.BBMT.2014.05.016 |
P698 | PubMed publication ID | 24862637 |
P50 | author | Federica Galaverna | Q57046114 |
Riccardo Varaldo | Q84914791 | ||
P2093 | author name string | Francesca Gualandi | |
Andrea Bacigalupo | |||
Maria Teresa Van Lint | |||
Sarah Pozzi | |||
Silvia Luchetti | |||
Anna Maria Raiola | |||
Carmen di Grazia | |||
Teresa Lamparelli | |||
Stefania Bregante | |||
Alessandra Stasia | |||
Anna Ghiso | |||
P433 | issue | 9 | |
P304 | page(s) | 1440-1443 | |
P577 | publication date | 2014-05-24 | |
P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
P1476 | title | CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation | |
P478 | volume | 20 |
Q98893607 | Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation |
Q34413233 | Alpha/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donors |
Q95661285 | Conditioning regimen for allogeneic bone marrow transplantation in children with acquired bone marrow failure: fludarabine/melphalan vs. fludarabine/cyclophosphamide |
Q91212144 | Eltrombopag for post-transplant cytopenias due to poor graft function |
Q52780773 | Fresh or Cryopreserved CD34+-Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function after Allogeneic Hematopoietic Cell Transplantation. |
Q88560885 | Graft failure after allogeneic hematopoietic stem cell transplantation |
Q38879870 | Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis |
Q37327622 | Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants |
Q64249488 | Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion |
Q64983057 | Placenta-Derived Adherent Stromal Cell Therapy for Hematopoietic Disorders: A Case Study of PLX-R18. |
Q41483852 | Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation. |
Q40466615 | The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function. |
Q96640810 | Therapy of posttransplant poor graft function with eltrombopag |
Q58122392 | [Effects of CD34(+) selected stem cells for the treatment of poor graft function after allogeneic stem cell transplantation] |
Search more.